Showing 1 - 10 of 19,764
Background: Lung cancer is one of the leading causes of cancer deaths. Treatment goals are the relief of symptoms and the increase of overall survival. With the rising number of treatment alternatives, the need for comparable assessments of health-related quality of life (HRQoL) parameters...
Persistent link: https://www.econbiz.de/10009755973
An important consideration when establishing priorities in health care is the likely effect that alternative allocations will have on the health-related quality of life (HRQoL) of the relevant population. This chapter considers some of the important issues surrounding the description and...
Persistent link: https://www.econbiz.de/10014024173
Persistent link: https://www.econbiz.de/10011299553
Persistent link: https://www.econbiz.de/10013173143
Persistent link: https://www.econbiz.de/10012221994
Background: Lung cancer is one of the leading causes of cancer deaths. Treatment goals are the relief of symptoms and the increase of overall survival. With the rising number of treatment alternatives, the need for comparable assessments of health-related quality of life (HRQoL) parameters...
Persistent link: https://www.econbiz.de/10010317143
Persistent link: https://www.econbiz.de/10011304921
The EORTC-C30 and EORTC-LC13 are the most frequently used health-related quality of life measurement instruments in pharmacological lung cancer trials. </AbstractSection> Copyright Damm et al.; licensee Springer. 2013
Persistent link: https://www.econbiz.de/10010998794
Persistent link: https://www.econbiz.de/10009404236
Persistent link: https://www.econbiz.de/10011299644